Grant: Doctoral Research Award: Priority Announcement - Infection and Immunity
McMaster University
$105,000.00
Investigating the role of adherent-invasive E. coli in the pathogenesis of Crohn's disease
FY 2015-16
Summary
Crohn's disease (CD) is a lifelong, debilitating illness which is notorious for causing wide variety of symptoms anywhere along with intestinal tract. Canada has one of the highest rates of CD in the world and the disease has a substantial financial burden on the healthcare system. Genetic and environmental risk factors have been associated with CD along with increased levels of bacteria known as adherent-invasive E. coli (AIEC). Our lab has developed a model for long-term AIEC infection in mice which results in intestinal inflammation similar to Crohn's disease in humans. While AIEC are found in most CD patients, AIEC can also be found in healthy patients suggesting that additional factors such as the patient's genetics or intestinal flora are needed for disease expression. My objective is to use our mouse model to determine the impact of known genetic and environmental risk factors on AIEC infection and associated inflammation. I hypothesize that different host genetics and xenobiotics influence AIEC colonization and therefore impact disease expression. I have already shown that one genetic risk factor for Crohn's unexpectedly appears to reduce AIEC colonization, indicating that indeed host genetics does play a role in AIEC colonization behaviour. I will also test how antibiotic exposure and other xenobiotics currently used in CD therapy influence AIEC colonization and host response. This research will lead to a better understanding of how various CD risk factors converge on host biology and will influence future new therapies for CD.
Department
Program
Doctoral Research Award: Priority Announcement - Infection and Immunity
Recipient
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
338237
Name
Oberc Alexander
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Infection and Immunity
Theme2
Biomedical
Prcname2
Doctoral Research Awards - A
Projecttitle
Investigating the role of adherent-invasive E. coli in the pathogenesis of Crohn's disease
Programtype2
Studentship Programs
Orgnameinp2
McMaster University
Cihramount2
$105,000
Cihrequipment2
$0
Programname2
Doctoral Research Award: Priority Announcement - Infection and Immunity
Keyworddelim
Antibiotics; Crohn'S Disease; Host Genetics; Immunology; Microbiology
Abstract
Crohn's disease (CD) is a lifelong, debilitating illness which is notorious for causing wide variety of symptoms anywhere along with intestinal tract. Canada has one of the highest rates of CD in the world and the disease has a substantial financial burden on the healthcare system. Genetic and environmental risk factors have been associated with CD along with increased levels of bacteria known as adherent-invasive E. coli (AIEC). Our lab has developed a model for long-term AIEC infection in mice which results in intestinal inflammation similar to Crohn's disease in humans. While AIEC are found in most CD patients, AIEC can also be found in healthy patients suggesting that additional factors such as the patient's genetics or intestinal flora are needed for disease expression. My objective is to use our mouse model to determine the impact of known genetic and environmental risk factors on AIEC infection and associated inflammation. I hypothesize that different host genetics and xenobiotics influence AIEC colonization and therefore impact disease expression. I have already shown that one genetic risk factor for Crohn's unexpectedly appears to reduce AIEC colonization, indicating that indeed host genetics does play a role in AIEC colonization behaviour. I will also test how antibiotic exposure and other xenobiotics currently used in CD therapy influence AIEC colonization and host response. This research will lead to a better understanding of how various CD risk factors converge on host biology and will influence future new therapies for CD.
Competitiondate
201510
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Oberc, Alexander
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $105,000~ $0~